This review summarizes the classification, contraindications for closure, and management strategies for patients with atrial septal defects complicated by pulmonary arterial hypertension.
No takes yet. Share an insight, caveat, or question.
Informs ASD-PH management decisions; extends classifications while leaving optimal closure thresholds open for prospective trials.
Nashat et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: